RxDoctor Payments Data

Melissa Zoumberos, MD

Colon & Rectal Surgery · Asheville, NCNPI 1295178986

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Intuitive Surgical at 48.4% of the total. Reporting peaked in 2019 at $2,843 and has fallen 99.9% since, to $3 in 2025.

$4,004in general payments, 2019–2025

Across 35 payments — averaging $114.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$2K
  • Stryker$866
  • THD America, Inc.$814
  • Pacira Pharmaceuticals Incorporated$119
  • GSK$104
  • Applied Medical Resources Corporation$67
  • plus $95 from 4 others

What the payments were for

  • Travel & lodging$1,84446%
  • Food & beverage$1,16029%
  • Education$1,00025%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,004 in reported general payments places this provider in the 60th percentile of 27 colon & rectal surgery providers in North Carolina.

See all colon & rectal surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$91,566
Medicare patients
141
Services billed
407

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SuprepSodium, Potassium,mag Sulfates13$1,490
Neomycin Sulfate26$114
Metronidazole31$46

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →